Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasound's ScanNav Anatomy Peripheral Nerve Block (PNB) - US v1.0

31 mars 2022 uppdaterad av: IntelligentUltrasound Limited
This is a single-center, prospective study to be undertaken at University of Oregon, Portland, USA. The aim is to evaluate the clinical performance of ScanNav Anatomy PNB when highlighting anatomical structures during UGRA scanning. Specifically, we aim to assess and quantify the correct/incorrect highlighting of anatomical structures associated with ScanNav Anatomy PNB during UGRA scanning.

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

Background:

The American Society of Regional Anesthesia and Pain Medicine (ASRA) has published evidence-based assessment of ultrasound-guided regional anesthesia (Neal et al., 2010) concluding that ultrasound guidance is superior or equal to other non-ultrasound nerve localization techniques. A subsequent publication from ASRA (Neal et al., 2016), has strengthened their position of ultrasound guidance being superior than other methods, including for the reduction of local anesthetic systemic toxicity. However, ultrasound-guided regional anesthesia (UGRA) is a difficult technique to master. A key activity of UGRA is ultrasound image interpretation (Sites et al., 2009) which ScanNav Anatomy PNB is designed to support. The data collected during this study will be assessed by a panel of intended users (experts in UGRA) to evaluate the performance and safety of ScanNav Anatomy PNB device highlighting.

Statistical Methodology:

Validation analyses will be conducted once the data collection has been complete. The collected scans will be processed, and the device output will be generated post hoc. Device output will be presented with raw ultrasound side-by-side. A panel of at least three expert anesthesiologists will review and evaluate each processed scan. The majority view of the panel will be used to evaluate each endpoint for any given structure ScanNav Anatomy PNB is intended to highlight.

Data collection and scan processing:

40 different subjects will be scanned. The dataset will be balanced to contain approximately equal numbers of subjects with BMI<30 and BMI>= 30 kg/m2.

All data collection will be performed with FDA cleared general purpose ultrasound machine, ScanNav Anatomy PNB device will not be used during data collection.

Data characteristics for scan subjects (e.g., age and BMI) will be reported. Ultrasound scans for all 9 supported anatomical regions will be collected from both sides of each subject.

90 x 10s clips per supported anatomical region will be generated, consisting of:

  • 80 x 10s scene clips: the block view (chosen by the expert scanner) together with the preceding 10 seconds of ultrasound scanning will be recorded (without the use of ScanNav Anatomy PNB)
  • 10 x 10s non-scene clips: 10 second ultrasound scans will be recorded at non-optimum block views, chosen by the expert scanner to represent plausible scanning errors (without the use of ScanNav Anatomy PNB) Scenes and non-scenes will be analyzed separately. Unmodified ultrasound video and highlighted video (color overlay produced by ScanNav Anatomy PNB generated post-hoc) will be presented side-by-side to independent experts for data analysis.

Data analysis:

Every clip will be presented to a minimum of 3 independent expert reviewers. All clips from a single anatomical region will be reviewed by the same 3 reviewers. Experts may review more than one anatomical region, but not necessarily all anatomical regions. Thus, a range of experts will review all anatomical regions.

Reviewers will be asked structured questions to assess the highlighting of safety critical anatomical structures (see definitions later in document) and the performance of ScanNav Anatomy PNB output for each individual clip.

The majority opinion (at least 2/3) will be obtained to establish the overall panel opinion (e.g., yes/yes/no = yes) for each structure on each clip.

Data will be evaluated and presented by structure in each anatomical region and overall (i.e., total for each class; nerve, artery etc.).

Inter-rater agreement between the reviewers will be reported on an anatomical region basis.

Data will be presented as frequencies and presented as percent of total clips analyzed.

Data analysis will include stratification by subject age, BMI, and ultrasound machine to ensure consistency across these variables.

Studietyp

Observationell

Inskrivning (Faktisk)

40

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Oregon
      • Portland, Oregon, Förenta staterna, 97239
        • Oregon Health & Science University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 60 år (Vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Potential study subjects will be healthy volunteers, chosen to provide a variety of ages and BMIs. Subjects will be screened to ensure approximate equal numbers in coverage for BMI (<30, 30-39) category.

Beskrivning

Inclusion Criteria:

  • Male or female, at least 18 years of age;
  • Able to comprehend and sign the Informed Consent prior to enrolment in the study.
  • Vaccinated against SARS-CoV-2

Exclusion Criteria:

  • Aged <18 years of age;
  • Unwilling or unable to provide informed consent.
  • BMI> 39 kg/m2
  • Known pathology of the area to be scanned

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
volunteer group - BMI less than 30
Each subject with a BMI less than 30 will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
Each subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
volunteer group - BMI of 30 and above
Each subject with a BMI of 30 and above will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
Each subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
ScanNav Anatomy PNB highlighting misidentification of structures
Tidsram: 6 months
Frequency of misidentification of structures [% of total, per anatomical region]
6 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
ScanNav Anatomy PNB highlighting identification of structures
Tidsram: 6 months
Frequency of correct identification of structures [% of total] and Frequency of non-identification of structures [% of total]
6 months
ScanNav Anatomy PNB safety issues
Tidsram: 6 months
Frequency of safety issues [% of total]
6 months
ScanNav Anatomy PNB adverse events
Tidsram: 6 months
Frequency of highlighting risking an adverse event [% of total]
6 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Glenn Woodworth, MD, Oregon Health and Science University
  • Huvudutredare: James Bowness, MD, University of Oxford & Royal Gwent Hospital

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

16 maj 2021

Primärt slutförande (Faktisk)

16 maj 2021

Avslutad studie (Faktisk)

30 november 2021

Studieregistreringsdatum

Först inskickad

25 maj 2021

Först inskickad som uppfyllde QC-kriterierna

25 maj 2021

Första postat (Faktisk)

28 maj 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

1 april 2022

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

31 mars 2022

Senast verifierad

1 juni 2021

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • IU2021_AG_07

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Ja

produkt tillverkad i och exporterad från U.S.A.

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera